Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Bristol/Myers Squibb Co

Recent news which mentions Bristol/Myers Squibb Co

< Previous 1 2 3 Next >
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
Tags Investment strategy Stock Picks Markets
From CNBC.com News
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
Tags Earnings Health care industry Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Bristol/Myers Squibb Co Pfizer Inc Merck & Co Inc
From CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
Tags NVIDIA Corp Markets Stock Picks
From CNBC.com News
5 things to know before the stock market opens Friday
Tags Technology Politics Markets
From CNBC.com News
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
Tags Health & Science Breaking News: Business Business News
From CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Tags AstraZeneca PLC Health & Science Bristol/Myers Squibb Co
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Health care industry Politics Merck & Co Inc
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Breaking news Health & Science Business News
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Health & Science Breaking News: Politics Abbvie Inc
From CNBC.com News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
Tags Health & Science Breaking News: Business Business News
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Johnson & Johnson Health care industry Novartis AG
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Tesla Inc Mattel Inc
From CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Tags Biotechnology GSK plc Zoom Video Communications Inc
From CNBC.com News
Cramer's Lightning Round: 'I would not abandon' Cava
Tags Mad Money S&P 500 Viking Therapeutics Inc
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Merck & Co Inc Biotech and Pharmaceuticals Pfizer Inc
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Investing Business News U/S/ Markets
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Biotech and Pharmaceuticals Bristol/Myers Squibb Co Investment strategy
From CNBC.com News
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
Tags Pharmaceuticals Business Government and politics
From CNBC.com News
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
Tags Business Pharmaceuticals Breaking news
From CNBC.com News
5 things to know before the stock market opens Monday
Tags International Business Machines Corp Mattel Inc JetBlue Airways Corp
From CNBC.com News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
Tags Bristol/Myers Squibb Co Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
Tags Pharmaceuticals Business Health & Science
From CNBC.com News
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
Tags Pharmaceuticals Business Business News
From CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
Tags Johnson & Johnson Health care industry Congress
From CNBC.com News
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
Tags Energy Merck & Co Inc Bristol/Myers Squibb Co
From CNBC.com News
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
Tags Business Pharmaceuticals Biotechnology
From CNBC.com News
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
Tags Health & Science Bristol/Myers Squibb Co Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology Boeing Co Alphabet Inc
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Health care industry Johnson & Johnson Karuna Therapeutics Inc
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.